Compare KMDA & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KMDA | USNA |
|---|---|---|
| Founded | 1990 | 1992 |
| Country | Israel | United States |
| Employees | 374 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 385.3M | 362.9M |
| IPO Year | N/A | 1996 |
| Metric | KMDA | USNA |
|---|---|---|
| Price | $6.97 | $19.70 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $13.00 | ★ $36.00 |
| AVG Volume (30 Days) | 66.9K | ★ 238.4K |
| Earning Date | 11-10-2025 | 10-22-2025 |
| Dividend Yield | ★ 2.96% | N/A |
| EPS Growth | ★ 30.41 | N/A |
| EPS | 0.35 | ★ 0.90 |
| Revenue | $174,787,000.00 | ★ $912,670,000.00 |
| Revenue This Year | $14.49 | $9.87 |
| Revenue Next Year | $10.12 | N/A |
| P/E Ratio | ★ $19.14 | $21.87 |
| Revenue Growth | ★ 10.36 | 5.88 |
| 52 Week Low | $5.54 | $18.48 |
| 52 Week High | $9.16 | $40.42 |
| Indicator | KMDA | USNA |
|---|---|---|
| Relative Strength Index (RSI) | 53.31 | 42.59 |
| Support Level | $6.70 | $18.48 |
| Resistance Level | $6.83 | $20.00 |
| Average True Range (ATR) | 0.16 | 0.51 |
| MACD | -0.01 | 0.29 |
| Stochastic Oscillator | 47.65 | 62.64 |
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.